Literature DB >> 32077673

Sitagliptin relieves diabetic nephropathy fibrosis via the MAPK/ERK signaling pathway.

Shufeng Cheng1, Liang Li2, Chunquan Song3, Huijing Jin4, Shouguo Ma5, Ping Kang6.   

Abstract

Entities:  

Year:  2020        PMID： 32077673     DOI： 10.23736/S0391-1977.20.03122-3

Source DB:  PubMed          Journal:  Minerva Endocrinol        ISSN： 0391-1977            Impact factor:   2.184


× No keyword cloud information.
  3 in total

Review 1.  Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.

Authors:  Sandra Rayego-Mateos; José Luis Morgado-Pascual; Lucas Opazo-Ríos; Melania Guerrero-Hue; Cristina García-Caballero; Cristina Vázquez-Carballo; Sebastián Mas; Ana Belén Sanz; Carmen Herencia; Sergio Mezzano; Carmen Gómez-Guerrero; Juan Antonio Moreno; Jesús Egido
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 5.923

Review 2.  The Impact of lncRNA on Diabetic Kidney Disease: Systematic Review and In Silico Analyses.

Authors:  Yunyun Zhao; Guanchi Yan; Jia Mi; Guoqiang Wang; Miao Yu; Di Jin; Xiaolin Tong; Xiuge Wang
Journal:  Comput Intell Neurosci       Date:  2022-04-27

3.  Diphenyl Diselenide Alleviates Tert-Butyl Hydrogen Peroxide-Induced Oxidative Stress and Lipopolysaccharide-Induced Inflammation in Rat Glomerular Mesangial Cells.

Authors:  Xing Wang; Yi Huan; Shuainan Liu; Caina Li; Hui Cao; Lei Lei; Quan Liu; Wenming Ji; Sujuan Sun; Kaixun Huang; Jun Zhou; Zhufang Shen
Journal:  Int J Mol Sci       Date:  2022-09-23       Impact factor: 6.208
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.